A program to improve lifestyle behaviors in young women with breast cancer

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates a hybrid multidisciplinary intervention aimed at promoting healthy lifestyle changes among young women diagnosed with breast cancer. Participants will be randomly assigned to either a group receiving a hybrid lifestyle education intervention or a group receiving individualized hybrid lifestyle interventions. The program incorporates various disciplines, including oncology, nutrition, physiotherapy, and psychology, to address both external and internal factors affecting health outcomes. The goal is to modify the personal and internal exposome to improve treatment responses and overall well-being.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN
* Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments.
* Signed the informed consent form
* Have access to a mobile phone or any electronic device with an active internet connection to receive the program information.

Exclusion Criteria:

* Patients with inflammatory cancer
* Those with cardiomyopathy or ventricular dysfunction (NYHA \>II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months
* Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome
* Unable to walk for at least 1 km
* Have cardiovascular, respiratory, or musculoskeletal diseases that impede physical activity
* Pregnant or breastfeeding
* Have psychiatric conditions impeding active participation in this protocol
* Do not understand Spanish

Where it's running

• Dr. Marlid Cruz Ramos
  México, Mexico Recruiting

Study contacts

• Study coordinator: Marlid Cruz Ramos, PhD
• Email: marlid.cruz@gmail.com
• Phone: +525556280400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AI-powered mobile app to support chemotherapy for breast cancer

  A mobile app in Arabic uses AI to help women undergoing chemotherapy see if it can improve symptom control and medication adherence compared with standard care.

  Recruiting University of Baghdad · Baghdad · NCT07273812

• Cryoablation for small breast tumors (SIX)

  This study will test whether cryoablation works as well as standard breast surgery for people with small (≤2.0 cm), unifocal early-stage breast cancer and will compare direct costs over one year.

  Recruiting Phase 3 Hospital do Coracao · São Paulo, São Paulo and 1 other locations · NCT06839001

• Predicting outcomes for advanced breast cancer patients treated with CDK4/6 inhibitors and endocrine therapy

  This study is trying to see how well different CDK4/6 inhibitors combined with hormone therapy work for people with advanced breast cancer and how safe they are.

  Recruiting at 24 sites Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Aviano and 23 other locations · NCT06805812

• Blood test to identify patients at high risk for breast cancer

  This study is testing a new blood test that uses advanced technology to see if it can help identify women at high risk for breast cancer.

  Recruiting at 2 sites EXoPERT · Honolulu, Hawaii and 2 other locations · NCT06672302

• HydroMARK Plus versus HydroMARK: comparing biopsy site marker retrieval and surgeon satisfaction

  This trial will test whether the HydroMARK Plus breast biopsy marker is retrieved more successfully than the current HydroMARK and whether surgeons are more satisfied with its removal for patients having biopsy clips removed during surgery.

  Recruiting University of Alabama at Birmingham · Birmingham, Alabama · NCT06294574

• Using tart cherry juice to prevent nerve damage from chemotherapy in breast cancer patients

  This study is testing if drinking tart cherry juice can help prevent nerve damage in breast cancer patients receiving chemotherapy.

  Recruiting Phase 2 University of California, Davis · Sacramento, California · NCT06268665

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.